| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 28 | 2021 | 419 | 3.760 |
Why?
|
| Heart Septal Defects, Atrial | 9 | 2014 | 37 | 2.370 |
Why?
|
| Heart Defects, Congenital | 16 | 2019 | 596 | 2.060 |
Why?
|
| Pulmonary Valve | 9 | 2021 | 40 | 1.810 |
Why?
|
| Pulmonary Valve Insufficiency | 8 | 2021 | 24 | 1.560 |
Why?
|
| Angioplasty, Balloon | 7 | 2019 | 110 | 1.510 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2019 | 178 | 1.340 |
Why?
|
| Foramen Ovale, Patent | 7 | 2021 | 21 | 1.090 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2017 | 450 | 1.030 |
Why?
|
| Septal Occluder Device | 6 | 2021 | 21 | 1.020 |
Why?
|
| Transposition of Great Vessels | 4 | 2020 | 51 | 1.000 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2021 | 164 | 0.920 |
Why?
|
| Stents | 7 | 2020 | 657 | 0.900 |
Why?
|
| Postoperative Complications | 9 | 2019 | 1615 | 0.800 |
Why?
|
| Prostheses and Implants | 4 | 2007 | 159 | 0.790 |
Why?
|
| Pulmonary Atresia | 2 | 2019 | 6 | 0.750 |
Why?
|
| Treatment Outcome | 30 | 2021 | 7029 | 0.710 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2014 | 100 | 0.700 |
Why?
|
| Fontan Procedure | 2 | 2019 | 129 | 0.680 |
Why?
|
| Embolization, Therapeutic | 3 | 2013 | 150 | 0.670 |
Why?
|
| Stenosis, Pulmonary Artery | 1 | 2019 | 3 | 0.660 |
Why?
|
| Monitoring, Ambulatory | 1 | 2019 | 84 | 0.650 |
Why?
|
| Echocardiography | 7 | 2016 | 515 | 0.630 |
Why?
|
| Hypoplastic Left Heart Syndrome | 4 | 2016 | 138 | 0.610 |
Why?
|
| Ultrasonography, Interventional | 3 | 2010 | 119 | 0.600 |
Why?
|
| Prosthesis Design | 11 | 2021 | 301 | 0.580 |
Why?
|
| Ventricular Outflow Obstruction | 5 | 2019 | 36 | 0.570 |
Why?
|
| Pulmonary Artery | 7 | 2013 | 323 | 0.550 |
Why?
|
| Heart Ventricles | 7 | 2017 | 738 | 0.550 |
Why?
|
| Heart Valve Prosthesis | 5 | 2019 | 222 | 0.520 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2006 | 7 | 0.500 |
Why?
|
| Humans | 63 | 2021 | 68618 | 0.490 |
Why?
|
| Catheter Ablation | 4 | 2007 | 229 | 0.490 |
Why?
|
| Child, Preschool | 16 | 2019 | 3187 | 0.480 |
Why?
|
| Secondary Prevention | 4 | 2020 | 291 | 0.470 |
Why?
|
| Viridans Streptococci | 1 | 2013 | 4 | 0.450 |
Why?
|
| Brain Abscess | 1 | 2013 | 7 | 0.450 |
Why?
|
| Norwood Procedures | 4 | 2016 | 61 | 0.440 |
Why?
|
| Vena Cava, Superior | 1 | 2013 | 41 | 0.440 |
Why?
|
| Streptococcal Infections | 1 | 2013 | 53 | 0.430 |
Why?
|
| Vascular Malformations | 1 | 2013 | 19 | 0.430 |
Why?
|
| Catheterization | 4 | 2011 | 209 | 0.430 |
Why?
|
| Heart Injuries | 1 | 2012 | 25 | 0.420 |
Why?
|
| Aortic Coarctation | 4 | 2016 | 37 | 0.400 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2020 | 373 | 0.390 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 54 | 0.360 |
Why?
|
| Heart Septum | 2 | 2010 | 84 | 0.360 |
Why?
|
| Body Weight | 3 | 2014 | 554 | 0.350 |
Why?
|
| Equipment Design | 5 | 2019 | 500 | 0.350 |
Why?
|
| Emergencies | 1 | 2010 | 107 | 0.340 |
Why?
|
| Heart Atria | 2 | 2010 | 206 | 0.340 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 85 | 0.340 |
Why?
|
| Stroke | 7 | 2021 | 2163 | 0.330 |
Why?
|
| Blalock-Taussig Procedure | 3 | 2013 | 20 | 0.330 |
Why?
|
| Adult | 26 | 2021 | 21403 | 0.330 |
Why?
|
| Infant, Newborn | 13 | 2016 | 2455 | 0.310 |
Why?
|
| Retrospective Studies | 19 | 2021 | 7277 | 0.310 |
Why?
|
| Cardiac Output | 1 | 2008 | 133 | 0.300 |
Why?
|
| Pulmonary Circulation | 1 | 2008 | 79 | 0.300 |
Why?
|
| Male | 33 | 2021 | 37321 | 0.300 |
Why?
|
| Device Removal | 4 | 2019 | 100 | 0.300 |
Why?
|
| Time Factors | 13 | 2020 | 4655 | 0.300 |
Why?
|
| Balloon Occlusion | 2 | 2008 | 22 | 0.300 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2008 | 134 | 0.290 |
Why?
|
| Atrial Fibrillation | 4 | 2021 | 249 | 0.280 |
Why?
|
| Risk Factors | 13 | 2020 | 5731 | 0.280 |
Why?
|
| Child | 15 | 2019 | 6405 | 0.280 |
Why?
|
| Infant | 12 | 2016 | 2891 | 0.280 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2006 | 73 | 0.270 |
Why?
|
| Fistula | 2 | 2017 | 29 | 0.260 |
Why?
|
| Aorta, Thoracic | 4 | 2016 | 211 | 0.260 |
Why?
|
| Prosthesis Implantation | 1 | 2006 | 83 | 0.260 |
Why?
|
| Recurrence | 7 | 2020 | 948 | 0.250 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 186 | 0.240 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 3259 | 0.240 |
Why?
|
| Prospective Studies | 10 | 2020 | 3705 | 0.230 |
Why?
|
| Tetralogy of Fallot | 3 | 2011 | 43 | 0.220 |
Why?
|
| Aortography | 3 | 2016 | 72 | 0.220 |
Why?
|
| Prosthesis Failure | 4 | 2019 | 130 | 0.220 |
Why?
|
| Aspirin | 2 | 2020 | 295 | 0.220 |
Why?
|
| Vena Cava Filters | 1 | 2003 | 18 | 0.220 |
Why?
|
| United States | 12 | 2019 | 7367 | 0.220 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 546 | 0.220 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 41 | 0.220 |
Why?
|
| Heart | 1 | 2008 | 850 | 0.220 |
Why?
|
| Adolescent | 17 | 2021 | 8912 | 0.210 |
Why?
|
| Embolism, Paradoxical | 3 | 2019 | 6 | 0.200 |
Why?
|
| Hemodynamics | 6 | 2020 | 705 | 0.200 |
Why?
|
| Ventricular Function | 2 | 2019 | 93 | 0.190 |
Why?
|
| Equipment Failure | 3 | 2012 | 112 | 0.190 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 25 | 0.180 |
Why?
|
| Palliative Care | 2 | 2016 | 271 | 0.180 |
Why?
|
| Foreign-Body Migration | 2 | 2012 | 38 | 0.180 |
Why?
|
| Female | 26 | 2020 | 38074 | 0.180 |
Why?
|
| Dipyridamole | 1 | 2020 | 26 | 0.180 |
Why?
|
| Feasibility Studies | 3 | 2013 | 652 | 0.170 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 89 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 536 | 0.170 |
Why?
|
| Clinical Trials as Topic | 3 | 2019 | 848 | 0.170 |
Why?
|
| Neurologists | 1 | 2019 | 15 | 0.170 |
Why?
|
| Echocardiography, Doppler | 2 | 2016 | 87 | 0.160 |
Why?
|
| Pressure | 1 | 2019 | 252 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2019 | 238 | 0.160 |
Why?
|
| Heart Arrest | 1 | 1999 | 113 | 0.160 |
Why?
|
| Young Adult | 9 | 2021 | 5717 | 0.150 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2017 | 33 | 0.150 |
Why?
|
| Thrombosis | 2 | 2011 | 218 | 0.150 |
Why?
|
| Vascular Fistula | 1 | 2017 | 5 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2019 | 622 | 0.150 |
Why?
|
| Ventricular Function, Right | 2 | 2015 | 103 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 214 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2016 | 34 | 0.130 |
Why?
|
| Electrocardiography | 3 | 2011 | 601 | 0.120 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2016 | 134 | 0.120 |
Why?
|
| Bioprosthesis | 2 | 2012 | 101 | 0.120 |
Why?
|
| Reoperation | 4 | 2019 | 467 | 0.120 |
Why?
|
| Angiography | 2 | 2006 | 194 | 0.120 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2014 | 38 | 0.110 |
Why?
|
| Exercise Test | 2 | 2015 | 242 | 0.110 |
Why?
|
| Age Factors | 4 | 2019 | 1864 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2014 | 45 | 0.110 |
Why?
|
| Phlebography | 1 | 2013 | 31 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 2324 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 1465 | 0.110 |
Why?
|
| Administration, Intravenous | 1 | 2013 | 89 | 0.110 |
Why?
|
| Pulmonary Veins | 2 | 2003 | 56 | 0.110 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2012 | 174 | 0.100 |
Why?
|
| Constriction, Pathologic | 4 | 2011 | 236 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 277 | 0.100 |
Why?
|
| Middle Aged | 9 | 2020 | 21147 | 0.100 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 14 | 0.100 |
Why?
|
| Brain Ischemia | 1 | 2017 | 665 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2011 | 94 | 0.090 |
Why?
|
| Hirudins | 1 | 2011 | 32 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2012 | 157 | 0.090 |
Why?
|
| Heart Bypass, Right | 1 | 2010 | 30 | 0.090 |
Why?
|
| Metals | 1 | 2010 | 100 | 0.090 |
Why?
|
| Punctures | 1 | 2010 | 35 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2010 | 79 | 0.090 |
Why?
|
| Exercise | 1 | 2015 | 658 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2012 | 322 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2010 | 113 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2011 | 483 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2012 | 2007 | 0.080 |
Why?
|
| Ebstein Anomaly | 1 | 2008 | 2 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2011 | 356 | 0.080 |
Why?
|
| MEDLINE | 1 | 2007 | 9 | 0.070 |
Why?
|
| Health Care Sector | 1 | 2007 | 26 | 0.070 |
Why?
|
| Embolism | 1 | 2007 | 45 | 0.070 |
Why?
|
| Contraindications | 1 | 2007 | 52 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 50 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2010 | 328 | 0.070 |
Why?
|
| Endocarditis | 2 | 2019 | 14 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 167 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2007 | 131 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 2223 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 2 | 2003 | 57 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2007 | 181 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2007 | 113 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 186 | 0.060 |
Why?
|
| Critical Illness | 1 | 2007 | 191 | 0.060 |
Why?
|
| Aged | 6 | 2014 | 14862 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 951 | 0.060 |
Why?
|
| Intention to Treat Analysis | 2 | 2017 | 38 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2013 | 792 | 0.060 |
Why?
|
| Europe | 2 | 2019 | 196 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 2334 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2003 | 20 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2018 | 506 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2003 | 80 | 0.060 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 121 | 0.060 |
Why?
|
| North America | 2 | 2013 | 112 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 109 | 0.050 |
Why?
|
| Registries | 1 | 2006 | 733 | 0.050 |
Why?
|
| Respiratory Paralysis | 1 | 2001 | 10 | 0.050 |
Why?
|
| Pulmonary Atelectasis | 1 | 2001 | 12 | 0.050 |
Why?
|
| Cardiology | 1 | 2003 | 140 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1046 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 4848 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 253 | 0.050 |
Why?
|
| Hypoxia | 1 | 2001 | 169 | 0.050 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2000 | 16 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.040 |
Why?
|
| Atrioventricular Node | 1 | 2000 | 39 | 0.040 |
Why?
|
| Arteries | 1 | 2020 | 108 | 0.040 |
Why?
|
| Prognosis | 3 | 2015 | 2093 | 0.040 |
Why?
|
| Intensive Care, Neonatal | 1 | 1999 | 38 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1753 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 141 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2000 | 167 | 0.040 |
Why?
|
| Compassionate Use Trials | 1 | 2018 | 2 | 0.040 |
Why?
|
| Canada | 1 | 2019 | 267 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 1420 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2077 | 0.040 |
Why?
|
| Consensus | 1 | 2019 | 211 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 109 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 649 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2000 | 232 | 0.040 |
Why?
|
| Survival Analysis | 1 | 1999 | 714 | 0.040 |
Why?
|
| Brazil | 2 | 2007 | 48 | 0.040 |
Why?
|
| Patient Safety | 1 | 2019 | 202 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 249 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1603 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 58 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 438 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 392 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 117 | 0.030 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 14 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 74 | 0.030 |
Why?
|
| Aging | 1 | 2000 | 911 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1140 | 0.030 |
Why?
|
| Blood Pressure | 1 | 1999 | 1451 | 0.030 |
Why?
|
| Cardiac Catheters | 1 | 2013 | 12 | 0.030 |
Why?
|
| Research Design | 2 | 2007 | 729 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2014 | 152 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2012 | 47 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 82 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2012 | 59 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 931 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2012 | 100 | 0.020 |
Why?
|
| Cause of Death | 1 | 2012 | 241 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 216 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2011 | 50 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1056 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2012 | 384 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 742 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 328 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 866 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 242 | 0.020 |
Why?
|
| England | 1 | 2007 | 64 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 2358 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 2007 | 77 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 72 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 320 | 0.020 |
Why?
|
| Mid-Atlantic Region | 1 | 2006 | 7 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 2176 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2003 | 36 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 255 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 772 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2003 | 100 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 183 | 0.010 |
Why?
|
| Diaphragm | 1 | 2001 | 22 | 0.010 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2000 | 12 | 0.010 |
Why?
|
| Action Potentials | 1 | 2000 | 223 | 0.010 |
Why?
|